why choose us

First received: July 23, 2024

Clinical Trial: A Study of CT-388 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Once-Weekly CT-388 Administered for 48 Weeks to Partici

Brief Summary: This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of CT-388 at low, middle, and high doses in participants with obesity or who are overweight with at least one weight-related comorbidity.

Read more